AT1

4.76%

2.2¢ atomo diagnostics limited

AT1 FY21 - General Discussion + FA, page-627

First 627 Last

Share
Profile

Follow
Soul13

521 Posts.

93

23/01/21

18:20

Post #: 50399949
Share

Originally posted by Soul13: ↑

COVID-19 Business Performance (FY20)
FY20 sales revenue of $5.4m
•COVID-19 Sales Revenue - $3.4m
NON-COVID Sales=$2m (assuming 500k in each quarter)
•COVID-19 Units Sold – 1.08m
3.4/1.08=$3.15 per device

NG Biotech (France) – high margin OEM contract for France and UK, 1.75m devices ordered to date (FY20)
If I interpreted correctly, the other 670k (1.75m-1.08m) devices sale were made in FY21
which is 670k*$3.15= $ 2.11m

Access Bio has placed an initial order for 259,200 Atomo devices to be used to build inventory of COVID-19 antibody tests in anticipation of US FDA approval.

DIVOC Labs has committed to an initial order of 77,000 units which will become effective upon receipt by DIVOC of regulatory approval of the product for professional use in India.

259200+77000=336200 devices in total* $3.15 = 1.059 m

Given the first quarter, AT1's sales were 2.5m and assuming the orders above turned into sales in the first two quarters.

The minimum amount of sales estimated for Q2 from the given data should be:
$ 2.11m + $1.059 m +$1.0m from Non-COVID side of business (assuming it is same as last year) - $2.5m from Q1 = $1.669m

There are a few other things I would like to know,
Has NG-biotech ordered more from us this quarter? If not, why not given the circumstances in Europe.
Has the other side of the business grown from last year? If so, how much? (given TGA approval for HIV tests, John also said in an interview that the HIV side of the business is doing better. And the success of AT1's partner Lumos)
Has AT1 applied for regulatory approval in SE Asian countries and Brazil? (if I remembered correctly) as they have the exclusive right to sell antibody tests.

PLEASE CORRECT ME IF I'M WRONG, as I do not have any experience in calculating this sort of stuff.

Cheers

Expand

Just a correction, since we don't have approval in India, the sales might not have made given the terms agreed.

So the minimum amount of sales estimated for Q2 from the given data should be:

$ 2.11m + $0.816 m +$1.0m from Non-COVID side of business (assuming it is same as last year) - $2.5m from Q1 = $1.426m

AT1 Price at posting: 30.0¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

A3D

Defence MOU for propulsion systems pushes Aurora Lab shares higher

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

IMA

Issues emerging as Australian companies tackle critical minerals challenge

CXU

Cauldron Energy reports "excellent" uranium assays in latest drill run

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

RAG

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

TIG

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

NWH

NRW Holdings inks $109M deal with BHP for works at Jimblebar

SHN

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

There are more pages in this discussion • 1,807 more messages in this thread...

First 627 Last

Add AT1 (ASX) to my watchlist

(20min delay)
Last 2.2¢		Change 0.001(4.76%)		Mkt cap ! $14.06M

Open	High	Low	Value	Volume
2.2¢	2.2¢	2.2¢	$4.382K	199.2K

Buyers (Bids)

No.	Vol.	Price($)
1	523	2.2¢

Sellers (Offers)

Price($)	Vol.	No.
2.3¢	224370	5

View Market Depth

No.	Vol.	Price($)
6	309815	0.020
6	593786	0.019
8	1107364	0.018
2	370000	0.017
1	62561	0.016

Price($)	Vol.	No.
0.023	224370	5
0.024	677560	4
0.025	466300	3
0.026	1200000	2
0.027	683000	3

Last trade - 16.10pm 11/10/2024 (20 minute delay)

AT1 (ASX) Chart

AT1 FY21 - General Discussion + FA, page-627

Defence MOU for propulsion systems pushes Aurora Lab shares higher

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Issues emerging as Australian companies tackle critical minerals challenge

Cauldron Energy reports "excellent" uranium assays in latest drill run

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

AT1 FY21 - General Discussion + FA, page-627

Top Stories

Defence MOU for propulsion systems pushes Aurora Lab shares higher

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Issues emerging as Australian companies tackle critical minerals challenge

Cauldron Energy reports "excellent" uranium assays in latest drill run

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News